This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anges Mg, Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Ko Hosokawa: Innovator in Tissue Survival Enhancement
Introduction
Ko Hosokawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of tissue engineering and organ transplantation. His innovative work focuses on enhancing the survival of musculocutaneous flaps and skin grafts through the use of growth factors.
Latest Patents
Ko Hosokawa holds 1 patent for his invention titled "Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival." This patent relates to the use of growth factors in improving tissue survival. Specifically, it describes methods for enhancing organ transplant, musculocutaneous flap, or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor.
Career Highlights
Throughout his career, Ko Hosokawa has been associated with Anges Mg, Inc., where he has worked on various projects aimed at improving medical outcomes through innovative solutions. His research has garnered attention for its potential applications in regenerative medicine.
Collaborations
Ko has collaborated with notable colleagues, including Tateki Kubo and Marvin A Tanag, to advance research in the field of tissue survival and transplantation.
Conclusion
Ko Hosokawa's contributions to the field of tissue engineering and organ transplantation highlight his role as an innovator dedicated to improving medical practices. His work continues to inspire advancements in regenerative medicine.